Nova (FRA:NMR) Total Liabilities: €889.3 Mil (As of Mar. 2026)


FRA:NMR Nova Ltd FRA:NMR
93 GF Score
Price €410.00
GF Value €266.93
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Nova Total Liabilities?

Nova FRA:NMR +2.71% 93 Total Liabilities is €889.3 Mil as of Mar. 2026. GuruFocus rates FRA:NMR with a GF Score™ of 93/100 and a GF Value™ of €266.93 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Nova's Total Liabilities for the quarter that ended in Mar. 2026 was €889.3 Mil.

Nova's quarterly Total Liabilities declined from Sep. 2025 (€968.51 Mil) to Dec. 2025 (€890.12 Mil) and declined from Dec. 2025 (€890.12 Mil) to Mar. 2026 (€889.31 Mil).

Nova's annual Total Liabilities increased from Dec. 2023 (€351.26 Mil) to Dec. 2024 (€441.81 Mil) and increased from Dec. 2024 (€441.81 Mil) to Dec. 2025 (€890.12 Mil).

Nova Total Liabilities Historical Data

* Premium members only.

The historical data trend for Nova's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Total Liabilities Chart

Nova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 293.29 374.90 351.26 441.81 890.12

Nova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 445.54 379.07 968.51 890.12 889.31
FRA:NMR
93GF Score
Nova Ltd FRA:NMR
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nova's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=191.753+(675.472+10.896
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+8.729+3.272+0)
=890.1

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2015.906-1125.784
=890.1

Nova's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=816.44+(50.199+14.602
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+8.07+0+0)
=889.3

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2089.573-1200.262
=889.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €889.3 Mil mean?
Nova (FRA:NMR) has a Total Liabilities of €889.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nova and its competitors.
Is Nova's Total Liabilities too high?
Nova's current Total Liabilities is €889.3 Mil. Overall, Nova has a GF Score™ of 93/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova's Total Liabilities compare to ONTO and AMKR?
Nova's Total Liabilities of €889.3 Mil can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Semiconductors company?
A good Total Liabilities depends on the Semiconductors industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Nova and its competitors. Nova's current Total Liabilities is €889.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova stock overvalued right now?
Based on GuruFocus' analysis, Nova (FRA:NMR) is currently considered Significantly Overvalued. The stock's GF Value™ is €266.93, compared to a current price of €410.00 — trading 53.6% above its estimated fair value. The current Total Liabilities is €889.3 Mil. Nova's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Nova (FRA:NMR), the current Total Liabilities is €889.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova (FRA:NMR) Overvalued in 2026?

Based on GuruFocus' analysis, Nova stock appears to be overvalued. The current stock price of €410.00 is trading 53.6% above its estimated GF Value™ of €266.93. GuruFocus considers Nova to be Significantly Overvalued.

Key valuation signals for FRA:NMR:

  • Total Liabilities: €889.3 Mil
  • GF Value™: €266.93 vs. price of €410.00 (53.6% above fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:NMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nova Business Description

Other Exchanges NVMI:USANVMI:Israel0YAA:UK
Address 5 David Fikes Street, 10th Floor, Rehovot, ISR, 7632805
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
93GF Score

Get the complete analysis for FRA:NMR

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€410.00
Price
€266.93
GF Value